<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Crystal structures of the CDK5-p25 kinase with bound inhibitors and substrate peptides</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2002-09-05">5 September 2002</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elena</forename><surname>Micossi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
									<postCode>ID14-2 ID14-2</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joanne</forename><surname>Mccarthy</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
									<postCode>ID14-2 ID14-2</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
									<postCode>ID14-2 ID14-2</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aldo</forename><surname>Tarricone</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
									<postCode>ID14-2 ID14-2</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
									<postCode>ID14-2 ID14-2</postCode>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Crystal structures of the CDK5-p25 kinase with bound inhibitors and substrate peptides</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2002-09-05">5 September 2002</date>
						</imprint>
					</monogr>
					<idno type="MD5">70ACCA8F90762E7A40641CD4CEA84874</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T22:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>CDK5 is a Cyclin-dependent Ser/Thr kinase acting in the central nervous system (CNS). Its activity requires the interaction with a protein known as p35. Deregulation of CDK5 activity as a consequence of proteolytic processing of the p35 sununit to a p25 moiety containing the C-terminal portion of p35 has been reported. It is deemed that CDK5 deregulation is important for the development of neuro-degenerative diseases such as amyotrophic lateral sclerosis and Alzheimer's disease. We have previously reported the crystal structure of the CDK5-p25 heterodimer <ref type="bibr" target="#b0">(Tarricone et al, 2001)</ref>. We are currently concentrating on the study of crystal structures of the heterodimeric enzyme with known and newly identified inhibitors of CDK5, to understand their mode of action, and to identify possible differences with other CDK-inhibitor interaction that may lead to the development of selective inhibitors. Furthemore, we would like to be able to raise crystals of the CDK5-p25 complex with peptide ligands. The existente of co-crystals of the kinase with substrates will shed light on the mechanisms of substrate recognition by this kinase, which are believed to be rather different from those of other known CDKs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>The most relevant recent endeavor in this project was the identification of a new trigonal crystal form with greatly improved properties relative to the initially identified monoclinic crystal form. The trigonal form diffracts at significantly higher resolution (up to 2.0 Å) and the overall quality of the diffraction pattern is remarkably increased for what concerns spot shape and mosaicity. The identification of the new crystal form allowed the collection of several datasets of CDK5-p25 in the presence of inhibitors and peptide substrates. A list of datasets collected is reported here. Data processing and crystal structure determination of the corresponding inhibitors bound to the CDK5 kinase is underway.</p></div>		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Structure and regulation of the CDK5-p25(nck5a) complex</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tarricone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dhavan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Areces</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L-H</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.2210/pdb1h4l/pdb</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Cell</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="117" to="123" />
			<date type="published" when="2001-05-11">2001</date>
			<publisher>Worldwide Protein Data Bank</publisher>
		</imprint>
	</monogr>
	<note>Structure and regulation of the CDK5-p25 complex</note>
	<note type="raw_reference">Tarricone C, Dhavan R, Peng J, Areces L, Tsai L-H, and Musacchio A (2001) Structure and regulation of the CDK5-p25 complex, Molecular Cell 8, 657-669 Short summary of collected data CDK5-p25-MeridianinE (1) Space Group P3221 Unit cell (Å) a=b=117.6, c=156.6</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
		<idno type="DOI">10.1002/crq.2018.35.issue-4</idno>
	</analytic>
	<monogr>
		<title level="j">Resolution (Å)</title>
		<idno type="ISSN">1536-5581</idno>
		<idno type="ISSNe">1541-1508</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="0" to="2" />
			<date type="published" when="2018-05" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Resolution (Å) 35.0-2.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Glutathione-S-transferase GliG (space group P3221)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Groll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Huber</surname></persName>
		</author>
		<idno type="DOI">10.2210/pdb7nc2/pdb</idno>
		<idno>c=156.8</idno>
		<imprint>
			<date type="published" when="2021-05-12" />
			<publisher>Worldwide Protein Data Bank</publisher>
			<biblScope unit="volume">5</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">CDK5-p25-MeridianinE (2) Space Group P3221 Unit cell (Å) a=b=117.5, c=156.8</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<idno type="DOI">10.1002/crq.2018.35.issue-4</idno>
	</analytic>
	<monogr>
		<title level="j">Resolution (Å)</title>
		<idno type="ISSN">1536-5581</idno>
		<idno type="ISSNe">1541-1508</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="0" to="2" />
			<date type="published" when="2018-05" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Resolution (Å) 35.0-2.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Hyperphosphorylation of tau by deregulated Cdk5 (Cdk5/p25) activity is inhibited by its truncated activator (p35)</title>
		<author>
			<persName><forename type="first">Varsha</forename><surname>Shukla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Harish</forename><forename type="middle">C</forename><surname>Pant</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neures.2011.07.804</idno>
		<idno>CDK5-p25</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroscience Research</title>
		<title level="j" type="abbrev">Neuroscience Research</title>
		<idno type="ISSN">0168-0102</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page">e186</biblScope>
			<date type="published" when="2011-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>a=b=117.3, c=156.4</note>
	<note type="raw_reference">CDK5-p25-MeridianinE-Tau peptide Space Group P3221 Unit cell (Å) a=b=117.3, c=156.4</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
		<idno type="DOI">10.1002/crq.2018.35.issue-4</idno>
	</analytic>
	<monogr>
		<title level="j">Resolution (Å)</title>
		<idno type="ISSN">1536-5581</idno>
		<idno type="ISSNe">1541-1508</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="0" to="2" />
			<date type="published" when="2018-05" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Resolution (Å) 35.0-2.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">Glutathione-S-transferase GliG (space group P3221)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Groll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Huber</surname></persName>
		</author>
		<idno type="DOI">10.2210/pdb7nc2/pdb</idno>
		<idno>35.0-2.2</idno>
		<imprint>
			<date type="published" when="2021-05-12" />
			<publisher>Worldwide Protein Data Bank</publisher>
		</imprint>
	</monogr>
	<note>a=b=117.4, c=156.8 Resolution (Å) 35.0-2.3 CDK5-p25-Hymenialdisine Space Group P3221 Unit cell (Å) a=b=117.4, c=156.5 Resolution (Å) 35.0-2.2 CDK5-p25-ADP-PNP Space Group P3221 Unit cell (Å) a=b=117.2, c=156.9 Resolution</note>
	<note type="raw_reference">CDK5-p25-MeridianinE-DARPP32 peptide Space Group P3221 Unit cell (Å) a=b=117.1, c=156.5 Resolution (Å) 35.0-2.1 CDK5-p25-alsterpaullone Space Group P3221 Unit cell (Å) a=b=117.4, c=156.8 Resolution (Å) 35.0-2.3 CDK5-p25-Hymenialdisine Space Group P3221 Unit cell (Å) a=b=117.4, c=156.5 Resolution (Å) 35.0-2.2 CDK5-p25-ADP-PNP Space Group P3221 Unit cell (Å) a=b=117.2, c=156.9 Resolution (Å) 35.0-2.2</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
